Piperidinyl prostaglandin analogs as ocular hypotensive agents

Details for Australian Patent Application No. 2005252171 (hide)

Owner Allergan, Inc.

Inventors Dinh, Danny T.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2005252171

PCT Pub. Number WO2005/121086

Priority 60/577,361 04.06.04 US

Filing date 16 May 2005

Wipo publication date 22 December 2005

International Classifications

C07D 211/76 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/121086 Priority application(s): WO2005/121086

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005252172-(diaryl-methyl)-malononitriles and their use as estrogen receptor ligands

2005252164-Adjustable sheet dispenser